Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.54 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18732399 | 0.96 | L3MBTL1 (0.57) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL26195602 | 0.94 | L3MBTL1 (0.73) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL21742574 | 0.92 | L3MBTL1 (0.57) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL10046782 | 0.91 | L3MBTL1 (0.52) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL19762128 | 0.91 | L3MBTL1 (0.52) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL19762150 | 0.91 | L3MBTL1 (0.52) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL19762190 | 0.91 | L3MBTL1 (0.52) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL21742661 | 0.89 | L3MBTL1 (0.59) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL12202811 | 0.89 | TSHR (0.68) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 | |
| SCHEMBL18731953 | 0.89 | L3MBTL1 (0.50) | L3MBTL1CYP1A2TSHRCYP2C19CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11680071-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| EP-3975280-A1 | COMPOSITION FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL Chemical & Material Co., Ltd. (JP) | 2022-03-30 | — | — | EP | disclosed |
| US-10910567-B2 | Double spiro-type compound and organic light emitting diode comprising same | LG CHEM, LTD. | 2021-02-02 | — | — | US | disclosed |
| US-10738034-B2 | Spiro compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2020-08-11 | — | — | US | disclosed |
| EP-3345982-B1 | DOUBLE SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-03-18 | — | — | EP | disclosed |
| WO-2020009076-A1 | POLYCARBONATE RESIN COMPOSITION | 帝人株式会社 | 2020-01-09 | — | — | WO | disclosed |
| CN-110054593-A | Method for synthesizing 1,3, 5-triazine derivative | 南京工业大学 | 2019-07-26 | — | — | CN | disclosed |
| WO-2019115423-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-06-20 | — | — | WO | disclosed |
| US-10249831-B2 | Electronic device containing cyclic lactams | MERCK PATENT GMBH (DE) | 2019-04-02 | — | — | US | disclosed |
| US-20180141933-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180040832-A1 | ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS | MERCK PATENT GMBH (DE) | 2018-02-08 | — | — | US | disclosed |
| WO-2018016742-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2018-01-25 | — | — | WO | disclosed |
| EP-3054498-B1 | BISIMIDAZODIAZOCINES | IDEMITSU KOSAN CO (JP) | 2017-09-20 | — | — | EP | disclosed |
| US-20170244044-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-24 | — | — | US | disclosed |
| US-20170244044-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-24 | — | — | US | disclosed |
| WO-2017089399-A1 | ORGANIC SEMICONDUCTIVE LAYER COMPRISING PHOSPHINE OXIDE COMPOUNDS | NOVALED GMBH (DE) | 2017-06-01 | — | — | WO | disclosed |
| WO-2017061810-A1 | DOUBLE SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2017-04-13 | — | — | WO | disclosed |
| WO-2016128103-A1 | ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS | MERCK PATENT GMBH (DE) | 2016-08-18 | — | — | WO | disclosed |
| WO-2016125110-A1 | BISIMIDAZOLODIAZOCINES | IDEMITSU KOSAN CO., LTD. (JP) | 2016-08-11 | — | — | WO | disclosed |
| EP-3054498-A1 | Bisimidazodiazocines | Idemitsu Kosan Co., Ltd. (JP) | 2016-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10738034-B2 | Spiro compound and organic light-emitting device comprising same | CRY1, NR2E3, ERG | L3MBTL1 2838/4885CYP1A2 436/4885TSHR 2800/4885 |
| US-10910567-B2 | Double spiro-type compound and organic light emitting diode comprising same | NR2E3, ALDH1A2, CRY1 | L3MBTL1 2416/4885CYP1A2 264/4885TSHR 2972/4885 |
| US-10249831-B2 | Electronic device containing cyclic lactams | OXA1L, UROD, MRPL21 | L3MBTL1 3138/4885CYP1A2 1135/4885TSHR 4257/4885 |
| US-20180141933-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, NR2E3, ERG | L3MBTL1 2838/4885CYP1A2 436/4885TSHR 2800/4885 |
| US-20180040832-A1 | ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS | OXA1L, UROD, MRPL21 | L3MBTL1 3138/4885CYP1A2 1135/4885TSHR 4257/4885 |
| US-11680071-B2 | Compound and organic light emitting device comprising the same | NCOA4, NR2E3, NCOA1 | L3MBTL1 1146/4885CYP1A2 85/4885TSHR 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.